Sky Fund invests $20m. in Barak 013

Also, Sky and Clal, together, will help Barak raise a further $30m. to buy back all of Barak's outstanding bonds worth $65m.

By SHARON WROBEL
March 22, 2006 07:27
barak 013 88

barak 013 88. (photo credit: )

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The Sky Private Equity Fund, founded by Zvi Yochman and Nir Dagan, will invest $20 million in Internet and telecom provider 013 Barak - half as equity and the other through convertible bonds. At the same time, Clal Industries and Investments of the IDB group, which controls Barak, will invest $15m. in the telecom provider through subsidiary Clalcom. Clal will invest $5m. as equity and the remaining $10m. in convertible bonds. Also, Sky and Clal, together, will help Barak raise a further $30m. to buy back all of Barak's outstanding bonds worth $65m. As a result of the process, Clal will own 60% of Barak and Sky 30% and Yochman will be named chairman of Barak.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS